{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:04:46Z","timestamp":1794607486451,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemotherapies may increase mutagenesis of healthy cells and change the selective pressures in tissues, thus influencing their evolution. However, their contributions to the mutation burden and clonal expansions of healthy somatic tissues are not clear. Here, exploiting the mutational footprint of some chemotherapies, we explore their influence on the evolution of hematopoietic cells. Cells of Acute Myeloid Leukemia (AML) secondary to treatment with platinum-based drugs show the mutational footprint of these drugs, indicating that non-malignant blood cells receive chemotherapy mutations. No trace of the\u00a05-fluorouracil (5FU) mutational signature is found in AMLs secondary to exposure to 5FU, suggesting that cells establishing the\u00a0leukemia could be quiescent during treatment. Using the platinum-based mutational signature as a barcode, we determine that the clonal expansion originating the secondary AMLs begins after the start of the cytotoxic treatment. Its absence in clonal hematopoiesis cases is consistent with the start of the clonal expansion predating the exposure to platinum-based drugs.<\/jats:p>","DOI":"10.1038\/s41467-021-24858-3","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T06:03:10Z","timestamp":1628575390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The evolution of hematopoietic cells under cancer therapy"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-1882","authenticated-orcid":false,"given":"Oriol","family":"Pich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-901X","authenticated-orcid":false,"given":"Albert","family":"Cortes-Bullich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-4168","authenticated-orcid":false,"given":"Ferran","family":"Mui\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pratcorona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-4660","authenticated-orcid":false,"given":"Abel","family":"Gonzalez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-8988","authenticated-orcid":false,"given":"Nuria","family":"Lopez-Bigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"24858_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"24858_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"24858_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tig.2012.01.003","volume":"28","author":"O Podlaha","year":"2012","unstructured":"Podlaha, O., Riester, M., De, S. & Michor, F. Evolution of the cancer genome. Trends Genet. 28, 155\u2013163 (2012).","journal-title":"Trends Genet."},{"key":"24858_CR4","first-page":"624","volume":"4","author":"M Cas\u00e1s-Selves","year":"2011","unstructured":"Cas\u00e1s-Selves, M. & DeGregori, J. How cancer shapes evolution, and how evolution shapes cancer. Evolution 4, 624\u2013634 (2011).","journal-title":"Evolution"},{"key":"24858_CR5","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41588-019-0525-5","volume":"51","author":"O Pich","year":"2019","unstructured":"Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732\u20131740 (2019).","journal-title":"Nat. Genet."},{"key":"24858_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/gm541","volume":"6","author":"SL Poon","year":"2014","unstructured":"Poon, S. L., McPherson, J. R., Tan, P., Teh, B. T. & Rozen, S. G. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med. 6, 24 (2014).","journal-title":"Genome Med."},{"key":"24858_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12594-8","volume":"10","author":"S Christensen","year":"2019","unstructured":"Christensen, S. et al. 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer. Nat. Commun. 10, 4571 (2019).","journal-title":"Nat. Commun."},{"key":"24858_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821\u2013836.e16 (2019).","journal-title":"Cell"},{"key":"24858_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15912-7","volume":"11","author":"NV Volkova","year":"2020","unstructured":"Volkova, N. V. et al. Mutational signatures are jointly shaped by DNA damage and repair. Nat. Commun. 11, 2169 (2020).","journal-title":"Nat. Commun."},{"key":"24858_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","volume":"580","author":"M Touat","year":"2020","unstructured":"Touat, M. et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580, 517\u2013523 (2020).","journal-title":"Nature"},{"key":"24858_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nrc722","volume":"2","author":"S Bhatia","year":"2002","unstructured":"Bhatia, S. & Sklar, C. Second cancers in survivors of childhood cancer. Nat. Rev. Cancer 2, 124\u2013132 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"24858_CR12","doi-asserted-by":"crossref","unstructured":"Bhatia, S. Therapy-related myelodysplasia and acute myeloid leukemia. Semin. Oncol. 40, 666\u2013675 (2013).","DOI":"10.1053\/j.seminoncol.2013.09.013"},{"key":"24858_CR13","doi-asserted-by":"crossref","unstructured":"Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).","DOI":"10.1126\/science.aan4673"},{"key":"24858_CR14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson, C. J. et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 367, 1449\u20131454 (2020).","journal-title":"Science"},{"key":"24858_CR15","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219\u20131226 (2020).","journal-title":"Nat. Genet."},{"key":"24858_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","volume":"23","author":"JI Hsu","year":"2018","unstructured":"Hsu, J. I. et al. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23, 700\u2013713.e6 (2018).","journal-title":"Cell Stem Cell"},{"key":"24858_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","volume":"22","author":"RL Bowman","year":"2018","unstructured":"Bowman, R. L., Busque, L. & Levine, R. L. Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell 22, 157\u2013170 (2018).","journal-title":"Cell Stem Cell"},{"key":"24858_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16805-5","volume":"11","author":"TH Mouhieddine","year":"2020","unstructured":"Mouhieddine, T. H. et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat. Commun. 11, 2996 (2020).","journal-title":"Nat. Commun."},{"key":"24858_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13542-2","volume":"10","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nat. Commun. 10, 5649 (2019).","journal-title":"Nat. Commun."},{"key":"24858_CR20","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","volume":"104","author":"AL Young","year":"2019","unstructured":"Young, A. L., Tong, R. S., Birmann, B. M. & Druley, T. E. Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica 104, 2410\u20132417 (2019).","journal-title":"Haematologica"},{"key":"24858_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamacardio.2019.0302","volume":"4","author":"O Calvillo-Arg\u00fcelles","year":"2019","unstructured":"Calvillo-Arg\u00fcelles, O. et al. Connections between clonal hematopoiesis, cardiovascular disease, and cancer: a review. JAMA Cardiol. 4, 380\u2013387 (2019).","journal-title":"JAMA Cardiol."},{"key":"24858_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.exphem.2019.12.006","volume":"83","author":"E Pardali","year":"2020","unstructured":"Pardali, E., Dimmeler, S., Zeiher, A. M. & Rieger, M. A. Clonal hematopoiesis, aging, and cardiovascular diseases. Exp. Hematol. 83, 95\u2013104 (2020).","journal-title":"Exp. Hematol."},{"key":"24858_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17459-z","volume":"11","author":"HJ Landau","year":"2020","unstructured":"Landau, H. J. et al. Accelerated single cell seeding in relapsed multiple myeloma. Nat. Commun. 11, 3617 (2020).","journal-title":"Nat. Commun."},{"key":"24858_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature13968","volume":"518","author":"TN Wong","year":"2015","unstructured":"Wong, T. N. et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518, 552\u2013555 (2015).","journal-title":"Nature"},{"key":"24858_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11037-8","volume":"10","author":"F Maura","year":"2019","unstructured":"Maura, F. et al. A practical guide for mutational signature analysis in hematological malignancies. Nat. Commun. 10, 2969 (2019).","journal-title":"Nat. Commun."},{"key":"24858_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"24858_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0963-7","volume":"17","author":"B Szikriszt","year":"2016","unstructured":"Szikriszt, B. et al. A comprehensive survey of the mutagenic impact of common cancer cytotoxics. Genome Biol. 17, 99 (2016).","journal-title":"Genome Biol."},{"key":"24858_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley, D. B., Harkin, D. P. & Johnston, P. G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330\u2013338 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"24858_CR29","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/molecules13081551","volume":"13","author":"N Zhang","year":"2008","unstructured":"Zhang, N., Yin, Y., Xu, S.-J. & Chen, W.-S. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 13, 1551\u20131569 (2008).","journal-title":"Molecules"},{"key":"24858_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-016-0311-6","volume":"7","author":"A Shaikh","year":"2016","unstructured":"Shaikh, A., Bhartiya, D., Kapoor, S. & Nimkar, H. Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem\/progenitor cells. Stem Cell Res. Ther. 7, 59 (2016).","journal-title":"Stem Cell Res. Ther."},{"key":"24858_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0306-3623(98)00191-8","volume":"31","author":"RM Mader","year":"1998","unstructured":"Mader, R. M., M\u00fcller, M. & Steger, G. G. Resistance to 5-fluorouracil. Gen. Pharmacol. Vasc. Syst. 31, 661\u2013666 (1998).","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"key":"24858_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"24858_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","volume":"52","author":"Z Hu","year":"2020","unstructured":"Hu, Z., Li, Z., Ma, Z. & Curtis, C. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat. Genet. 52, 701\u2013708 (2020).","journal-title":"Nat. Genet."},{"key":"24858_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2435-1","volume":"583","author":"SJ Aitken","year":"2020","unstructured":"Aitken, S. J. et al. Pervasive lesion segregation shapes cancer genome evolution. Nature 583, 265\u2013270 (2020).","journal-title":"Nature"},{"key":"24858_CR35","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","volume":"25","author":"FG Osorio","year":"2018","unstructured":"Osorio, F. G. et al. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 25, 2308\u20132316.e4 (2018).","journal-title":"Cell Rep."},{"key":"24858_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/281381a0","volume":"281","author":"H Gs","year":"1979","unstructured":"Gs, H. & Tr, B. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature 281, 381\u2013382 (1979).","journal-title":"Nature"},{"key":"24858_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.bjc.6605135","volume":"101","author":"N Ban","year":"2009","unstructured":"Ban, N. & Kai, M. Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia. Br. J. Cancer 101, 363\u2013371 (2009).","journal-title":"Br. J. Cancer"},{"key":"24858_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41556-019-0444-9","volume":"22","author":"A Batsivari","year":"2020","unstructured":"Batsivari, A. et al. Dynamic responses of the haematopoietic stem cell niche to diverse stresses. Nat. Cell Biol. 22, 7\u201317 (2020).","journal-title":"Nat. Cell Biol."},{"key":"24858_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"24858_CR40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","volume":"39","author":"CY Ok","year":"2015","unstructured":"Ok, C. Y. et al. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leuk. Res. 39, 348\u2013354 (2015).","journal-title":"Leuk. Res."},{"key":"24858_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc.2017.60","volume":"17","author":"ME McNerney","year":"2017","unstructured":"McNerney, M. E., Godley, L. A. & Le Beau, M. M. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat. Rev. Cancer 17, 513\u2013527 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"24858_CR42","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-020-0290-x (2020).","DOI":"10.1038\/s41568-020-0290-x"},{"key":"24858_CR43","doi-asserted-by":"publisher","unstructured":"Kattih, B. et al. IDH1\/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction\u2014a retrospective propensity score analysis. Leukemia https:\/\/doi.org\/10.1038\/s41375-020-01043-x (2020).","DOI":"10.1038\/s41375-020-01043-x"},{"key":"24858_CR44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/ajh.24072","volume":"90","author":"CD DiNardo","year":"2015","unstructured":"DiNardo, C. D. et al. Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML. Am. J. Hematol. 90, 732\u2013736 (2015).","journal-title":"Am. J. Hematol."},{"key":"24858_CR45","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","volume":"21","author":"CC Coombs","year":"2017","unstructured":"Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374\u2013382.e4 (2017).","journal-title":"Cell Stem Cell"},{"key":"24858_CR46","doi-asserted-by":"publisher","unstructured":"Pich, O., Reyes-Salazar, I., Gonzalez-Perez, A. & Lopez-Bigas, N. Discovering the drivers of clonal hematopoiesis. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2020.10.22.350140, https:\/\/doi.org\/10.1101\/2020.10.22.350140 (2020).","DOI":"10.1101\/2020.10.22.350140"},{"key":"24858_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson, S. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400\u2013404 (2018).","journal-title":"Nature"},{"key":"24858_CR48","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai, P. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat. Med. 24, 1015\u20131023 (2018).","journal-title":"Nat. Med."},{"key":"24858_CR49","doi-asserted-by":"crossref","unstructured":"Ng, A. W. T. et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med. 9, eaan6446 (2017).","DOI":"10.1126\/scitranslmed.aan6446"},{"key":"24858_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122\u2013128 (2020).","journal-title":"Nature"},{"key":"24858_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"24858_CR52","doi-asserted-by":"publisher","unstructured":"Sabarinathan, R. et al. The whole-genome panorama of cancer drivers. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/190330 (2017).","DOI":"10.1101\/190330"},{"key":"24858_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.celrep.2017.06.067","volume":"20","author":"A Unnikrishnan","year":"2017","unstructured":"Unnikrishnan, A. et al. Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes. Cell Rep. 20, 572\u2013585 (2017).","journal-title":"Cell Rep."},{"key":"24858_CR54","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","volume":"20","author":"Y Touil","year":"2014","unstructured":"Touil, Y. et al. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis. Clin. Cancer Res. 20, 837\u2013846 (2014).","journal-title":"Clin. Cancer Res."},{"key":"24858_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.7150\/ijbs.10248","volume":"11","author":"Z-Y Xu","year":"2015","unstructured":"Xu, Z.-Y. et al. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells. Int. J. Biol. Sci. 11, 284\u2013294 (2015).","journal-title":"Int. J. Biol. Sci."},{"key":"24858_CR56","doi-asserted-by":"publisher","unstructured":"Robinson, P. S. et al. Elevated somatic mutation burdens in normal human cells due to defective DNA polymerases. Preprint at https:\/\/doi.org\/10.1101\/2020.06.23.167668 (2020).","DOI":"10.1101\/2020.06.23.167668"},{"key":"24858_CR57","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463\u20131469 (2016).","journal-title":"Science"},{"key":"24858_CR58","doi-asserted-by":"crossref","unstructured":"McGranahan, N. & Swanton, C. Neoantigen quality, not quantity. Sci. Transl. Med. 11, eaax7918 (2019).","DOI":"10.1126\/scitranslmed.aax7918"},{"key":"24858_CR59","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"24858_CR60","doi-asserted-by":"crossref","unstructured":"Garcia, M. et al. Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants. F1000Research 9, (2020).","DOI":"10.12688\/f1000research.16665.2"},{"key":"24858_CR61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"24858_CR62","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"24858_CR63","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"24858_CR64","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"24858_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE Blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).","journal-title":"Sci. Rep."},{"key":"24858_CR66","doi-asserted-by":"publisher","first-page":"D876","DOI":"10.1093\/nar\/gkq963","volume":"39","author":"P Fujita","year":"2011","unstructured":"Fujita, P. a et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876\u2013D882 (2011).","journal-title":"Nucleic Acids Res."},{"key":"24858_CR67","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069\u20132070 (2010).","journal-title":"Bioinformatics"},{"key":"24858_CR68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","volume":"130","author":"MA Jensen","year":"2017","unstructured":"Jensen, M. A., Ferretti, V., Grossman, R. L. & Staudt, L. M. The NCI Genomic Data Commons as an engine for precision medicine. Blood 130, 453\u2013459 (2017).","journal-title":"Blood"},{"key":"24858_CR69","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"24858_CR70","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"24858_CR71","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"24858_CR72","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"24858_CR73","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246\u2013259 (2013).","journal-title":"Cell Rep."},{"key":"24858_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"24858_CR75","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"24858_CR76","doi-asserted-by":"publisher","first-page":"283ra54","DOI":"10.1126\/scitranslmed.aaa1408","volume":"7","author":"N McGranahan","year":"2015","unstructured":"McGranahan, N. et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 7, 283ra54 (2015).","journal-title":"Sci. Transl. Med."},{"key":"24858_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11383","volume":"7","author":"S Morganella","year":"2016","unstructured":"Morganella, S. et al. The topography of mutational processes in breast cancer genomes. Nat. Commun. 7, 11383 (2016).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24858-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24858-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24858-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:04:58Z","timestamp":1669971898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24858-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24858"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24858-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.29.360230","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4803"}}